VentriPoint Diagnostics (VPT) Stock Statistics & Valuation Metrics

VentriPoint Diagnostics has a market cap or net worth of C$25.43M. The enterprise value is C$26.94M.

VentriPoint Diagnostics has 188,345,760 shares outstanding. The number of shares has decreased by -2.65% in one year.

VentriPoint Diagnostics’s return on equity (ROE) is 0.78 and return on invested capital (ROIC) is 220.77%.

The current PE Ratio of VentriPoint Diagnostics is ―. VentriPoint Diagnostics’s PEG ratio is 0.19.

In the last 12 months, VentriPoint Diagnostics had revenue of 179.93K and earned -3.20M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -1.55M and capital expenditures -5.00, giving a free cash flow of -1.55M billion.

VentriPoint Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―

VentriPoint Diagnostics upcoming earnings date is Jun 2, 2026, Before Open (Confirmed).

VentriPoint Diagnostics as a current ratio of 0.08, with Debt / Equity ratio of -63.20%

In the past 12 months, VentriPoint Diagnostics has paid -52.20K in taxes.

VentriPoint Diagnostics EV to EBITDA ratio is -7.70, with an EV/FCF ratio of -16.53.

VentriPoint Diagnostics has C$55.39K in cash and marketable securities with C$2.60M in debt, giving a net cash position of -C$2.55M billion.

Gross margin is 82.94%, with operating margin of -1889.37%, and net profit margin of -1778.62%.

The average price target for VentriPoint Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―